Article

Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus

Department of Physiology, Ralph L. Smith Research Center, University of Kansas Medical Center, Kansas City 66160-7338, USA.
Molecular Endocrinology (Impact Factor: 4.2). 07/1995; 9(6):691-705. DOI: 10.1210/me.9.6.691
Source: PubMed

ABSTRACT A synchrony between the activated state of the blastocyst and differentiation of the uterus to the receptive state is essential to the process of implantation. This process is directed by progesterone (P4) and estrogen. The mechanism by which P4 differentiates the uterus, enabling estrogen to initiate implantation, is unknown but likely to involve localized induction of growth and differentiation factors. We have cloned the murine amphiregulin (AR) gene, a newly discovered member of the epidermal growth factor family, and demonstrate that its expression is implantation-specific and P4-regulated in the mouse uterus. A transient surge in AR mRNA levels occurred throughout the uterine epithelium on day 4 of pregnancy. With the onset of blastocyst attachment late on day 4, AR mRNA accumulated in the luminal epithelium exclusively at the sites of blastocysts. Thus, AR expression correlated first with rising P4 levels and then with the attachment reaction. The rapid induction of AR mRNA in the ovariectomized uterus only by P4 and abrogation of this induction by RU-486 (a P4 receptor antagonist) suggest that this uterine gene is regulated by P4. AR appeared to exhibit preferential phosphorylation of epidermal growth factor receptor in the uterus over that in the blastocyst. This is a first report of a P4-regulated uterine epithelial cell growth factor that is associated with epithelial cell differentiation during implantation. The association of AR in implantation is further documented by its down-regulation in the day 4 pregnant uterus in which uterine receptivity and implantation were disrupted by estrogen or RU-486 treatment on day 3. These results further indicate that the expression of the AR gene could serve as a molecular marker for the receptive state of the uterus for implantation.

Download full-text

Full-text

Available from: Sanjoy Das, Sep 04, 2015
1 Follower
 · 
88 Views
 · 
86 Downloads
  • Source
    • "AREG is the most highly expressed epidermal growth factor receptor (EGFR) ligand in ducts and end buds during puberty, and AREG is required for normal ductal morphogenesis [26]. P has also been shown to increase AREG expression in the adult mouse mammary gland [27] and mouse uterus [28]. Given the functional significance of AREG in E-induced EB formation, its high expression in the pubertal mammary gland compared with other EGFR ligands, and reported regulation of AREG by P, we hypothesized that P-induced EB formation was also mediated by AREG. "
    [Show abstract] [Hide abstract]
    ABSTRACT: INTRODUCTION: Puberty is a period of increased susceptibility to factors that cause increased breast cancer risk in adulthood. Mammary end buds (EB) that develop during puberty are believed to be the targets of breast cancer initiation. While the role of estrogen (E) has been extensively studied in pubertal mammary gland development, the role of progesterone (P) during puberty is less defined. METHODS: Pubertal and pre-pubertal ovariectomized mice were treated with vehicle control (C), E, P or E+P. Mammary glands from these mice were analyzed for changes in morphology, proliferation, and expression of the downstream targets amphiregulin (AREG) and Receptor Activator of NF-kB Ligand (RANKL). RESULTS: P, acting specifically through the progesterone receptor, induced increases in mammary gland proliferation and EB formation that were associated with increased AREG expression in ducts and EBs. E, acting specifically through the estrogen receptor, produced similar responses also mediated by AREG. Blocking AREG action by treatment with an epidermal growth factor receptor (EGFR) inhibitor completely abrogated the effect of P on EB formation and proliferation and significantly reduced proliferation within ducts. P also increased expression of RANKL, primarily in ducts. Treatment with RANK-Fc, an inhibitor of RANKL, reduced P-dependent proliferation in ducts and to a lesser extent in EB, but did not cause EB regression. CONCLUSIONS: These results demonstrate a novel P-specific effect through AREG to cause EB formation and proliferation in the developing mammary gland both prior to and during puberty. Thus, hormones and/or factors in addition to E that up-regulate AREG can promote mammary gland development and have the potential to affect breast cancer risk associated with pubertal mammary gland development.
    Breast cancer research: BCR 05/2013; 15(3):R44. DOI:10.1186/bcr3431 · 5.88 Impact Factor
  • Source
    • "Pubertal mammary gland development is largely controlled by E and P produced by the ovary. Both E and P can induce Areg which is an important paracrine factor for pubertal development [20] [33] [34]. Thus normal ovarian function is critical for pubertal "
    [Show abstract] [Hide abstract]
    ABSTRACT: Exposure to perfluorooctanoic acid (PFOA), a synthetic perfluorinated compound and an agonist of peroxisome proliferator-activated receptor α (PPARα), causes stunted mouse mammary gland development in various developmental stages. However, the underlying mechanisms remain poorly understood. We found that peripubertal PFOA exposure significantly inhibited mammary gland growth in both Balb/c and C57Bl/6 wild type mice, but not in C57Bl/6 PPARα knockout mice, and Balb/c mice were more sensitive to PFOA inhibition. PFOA caused (1) delayed or absence of vaginal opening and lack of estrous cycling during the experimental period; (2) decreases in ovarian steroid hormonal synthetic enzyme levels; and (3) reduced expression of estrogen- or progesterone-induced mammary growth factors. Supplementation with exogenous estrogen and/or progesterone reversed the PFOA inhibitory effect on mammary gland. These results indicate that PFOA effects on ovaries mediate its inhibition of mammary gland development in Balb/c and C57Bl/6 mice and that PPARα expression is a contributing factor.
    Reproductive Toxicology 03/2012; 33(4):563-76. DOI:10.1016/j.reprotox.2012.02.004 · 2.77 Impact Factor
  • Source
    • "Next, we examined whether, in the uteri of PR-A transgenics, there was an increase in progesterone/PR-dependent expression of growth factors by analyzing for amphiregulin. Amphiregulin was chosen as a marker because (i) it is regulated exclusively by progesterone in uterine epithelial cells, and (ii) the regulation of its expression by progesterone requires signaling through PR such that it is abolished upon treatment with antiprogestins (Das et al., 1995). Analyses for amphiregulin gene expression revealed that it was inducible by progesterone and not by estradiol in the uteri of ovariectomized PR-A transgenics. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A delicate balance in estrogen and progesterone signaling through their cognate receptors is characteristic for the physiologic state of the endometrium, and a shift in receptor isotype expression can be frequently found in human endometrial pathology. In this study, using a transgenic mouse model, we examined the mechanisms whereby alterations in progesterone receptor (PR) isotype expression leads to endometrial pathology. For an experimental model, we used transgenic mice (PR-A transgenics) carrying an imbalance in the native ratio of the two PR isoforms A and B (PR-A and PR-B) through the expression of additional A form and examined their uterine phenotype under different hormonal regimens, using various criteria. Uterine epithelial cell proliferation was augmented in PR-A transgenics and was abolished by PR antagonists. In particular, proliferative response to progesterone, independent of signaling through estrogen, was enhanced. Upon continuous exposure to estradiol and progesterone, the uteri in PR-A transgenics displayed gross enlargement, endometrial hyperplasia including atypical lesions, endometritis and pelvic inflammatory disease. Imbalanced expression of the two isoforms of PR in a transgenic model reveals multiple derangements in the regulation of uterine physiology, resulting in various pathologies including hyperplasias.
    Molecular Human Reproduction 03/2009; 15(4):241-9. DOI:10.1093/molehr/gap013 · 3.48 Impact Factor
Show more